1.
Talkowski ME, Maussion G, Crapper L, et al. Disruption of a large intergenic noncoding RNA in subjects with neurodevelopmental disabilities. Am J Hum Genet. 2012;91(6):1128-34. doi:10.1016/j.ajhg.2012.10.016.
1.
Chan C, Jayasekera S, Kao B, Páramo M, von Grotthuss M, Ranz JM. Remodelling of a homeobox gene cluster by multiple independent gene reunions in Drosophila. Nat Commun. 2015;6:6509. doi:10.1038/ncomms7509.
1.
Pugh TJ, Banerji S, Meyerson M. Pugh et al. reply. Nature. 2015;520(7547):E12-4. doi:10.1038/nature14266.
1.
Kim J, Won H-H, Kim Y, Choi JR, Yu N, Lee K-A. Breakpoint mapping by whole genome sequencing identifies PTH2R gene disruption in a patient with midline craniosynostosis and a de novo balanced chromosomal rearrangement. J Med Genet. 2015;52(10):706-9. doi:10.1136/jmedgenet-2015-103001.
1.
Laughney AM, Elizalde S, Genovese G, Bakhoum SF. Dynamics of Tumor Heterogeneity Derived from Clonal Karyotypic Evolution. Cell Rep. 2015;12(5):809-20. doi:10.1016/j.celrep.2015.06.065.
1.
Chapuy B, Roemer MGM, Stewart C, et al. Targetable genetic features of primary testicular and primary central nervous system lymphomas. Blood. 2016;127(7):869-81. doi:10.1182/blood-2015-10-673236.
1.
Drier Y, Cotton MJ, Williamson KE, et al. An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma. Nat Genet. 2016;48(3):265-72. doi:10.1038/ng.3502.
1.
Wala J, Beroukhim R. CANCER. The oncogene makes its escape. Science. 2016;351(6280):1398-9. doi:10.1126/science.aaf5542.
1.
Ryan RJH, Drier Y, Whitton H, et al. Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma. Cancer Discov. 2015;5(10):1058-71. doi:10.1158/2159-8290.CD-15-0370.